Establishment Labs

For this year's Breast Cancer Awareness Month, we organized a panel discussion featuring medical experts and a breast cancer survivor, focusing on holistic approaches to breast reconstruction. From cutting-edge surgical innovations to mental health support, the event sought to empower women at every stage of their journey. Thank you to all who participated and to our dedicated team of experts. Swipe through to see highlights from this meaningful event. #PurplePower #MotivaFlora #BreastCancerAwarenessMonth

We are very happy to share that our Motiva SmoothSilk® Round and SmoothSilk Ergonomix® breast implants have received Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) on September 26, 2024. This approval opens new doors for us and marks a significant step forward in our mission to redefine Breast Aesthetics with our Femtech solutions. Look at where teamwork, discipline, and dedication have brought us; and this is only the beginning.  #MotivaFemtech #MotivaUSA #SmoothSilk #TheMotivaStandard #MotivaImplants 

For more information visit https://lnkd.in/e66rUvQh

If you are looking for discreet, barely noticeable scars and natural-looking results, JOY.(dot)® might be for you. To learn more visit https://lnkd.in/dWt_PbWD JOY.(dot)® results and experiences may vary from consumer to consumer. Motiva Implants are currently not approved in the USA and are pending FDA approval. Szychta, P. Advancements in Aesthetic Breast Augmentation: Evaluating the Safety, Efficacy, and Naturalistic Outcomes of Ergonomix2 Implants. Aesth Plast Surg. 2024. https://lnkd.in/ddkheJQt #JOYdotMotiva #MotivaFemtech

We're excited to share our Q2 2024 achievements at Establishment Labs! We reported revenue of $44.1M, this was 18.7% quarter-over-quarter growth and showed strong market stabilization. We successfully completed the FDA pre-approval inspection, bringing us closer to launching Motiva Implants in the US. Our innovative products, Flora Tissue Expander and Mia Femtech, are gaining significant traction, with Mia Femtech expanding to 22 cities globally. We're proud of these milestones and look forward to continued growth and innovation! #femtech #motivaimplants #innovation #womenshealth

Six years ago, on a day like today, Establishment Labs became the first company from Costa Rica to be listed on the Nasdaq Stock Market. We're immensely proud to celebrate this sixth anniversary as a once-small Costa Rican company that dared to dream big! This is more than a marker of our past success; it is a beacon of our future potential. A huge thank you to our incredible investors—your support has made this possible. Visit our website to stay informed about our latest stock and investor information at the link: https://lnkd.in/eTStSu_V #ESTANasdaq #MotivaFemtech

As a Femtech company, we focus on innovation to improve the quality of life for women. A crucial element of our mission is to strive for Sustainable Growth, and we want to be fully transparent. That's why we are releasing our 2023 Annual Review. Feel free to read it here: https://lnkd.in/eq5qAPUZ. #MotivaFemtech #MotivaSustainableGrowth

At Establishment Labs, we celebrate diversity and inclusion as fundamental values that make us stronger. This month, we want to reinforce our commitment to inclusivity and recognize respect, diversity, and equal opportunities for everyone. Thanks to all of our employees!

Motiva advocates merging eco-conscious efforts with Women's Health technology to foster a future where economic growth and sustainability are inseparable. Join us in celebrating this year's World Environment Day! #GenerationRestoration #MotivaFemtech

Enhance your patients’ confidence and comfort with JOY.(dot)®️, a breast augmentation experience designed to provide natural-looking results with a barely noticeable scar! 💜 #JOYdotMotiva #MotivaFemTech Szychta, P. Advancements in Aesthetic Breast Augmentation: Evaluating the Safety, Efficacy, and Naturalistic Outcomes of Ergonomix2 Implants. Aesth Plast Surg. 2024. https://lnkd.in/ddkheJQt